Thoracic duct stent-graft decompression with 3-month patency: Revisiting a historical treatment option for portal

H McGregor1, G Woodhead1, M Patel1

  • 1Department of Medical Imaging, University of Arizona, Tucson, Arizona USA.

Lymphology
|November 15, 2020
PubMed

Insights

Thoracic duct stent-graft decompression effectively treated variceal hemorrhage in a cirrhosis patient. This minimally invasive approach shows promise for managing portal hypertension complications.

Area of Science:

  • Interventional Radiology
  • Hepatology
  • Vascular Surgery

Background:

  • Portal hypertension in cirrhosis leads to elevated thoracic duct flow and pressure.
  • Traditional treatments for portal hypertension complications include thoracic duct drainage and lymphovenous bypass.
  • Minimally invasive techniques are sought for managing complex cirrhotic complications.

Observation:

  • A patient with cirrhosis, portal hypertension, and variceal hemorrhage underwent thoracic duct stent-graft placement.
  • The procedure aimed to decompress the thoracic duct across the lymphovenous junction.
  • Initial venography showed partial stent-graft patency with fibrin sheath formation.

Findings:

  • Percutaneous thoracic duct stent-graft placement successfully resolved acute variceal hemorrhage.
  • Endoscopy confirmed decompression of bleeding varices post-procedure.
  • Stent-graft revision achieved full patency at 3-month follow-up, preventing recurrent hemorrhage.

Implications:

  • Thoracic duct stent-graft decompression offers a potential minimally invasive treatment for cirrhotic portal hypertension.
  • This technique may provide an alternative to traditional surgical interventions for variceal bleeding.
  • Further research is warranted to establish the long-term efficacy and safety of this approach.